Ohio Innovation Fund was among the shareholders who returned for Enable Injections’ latest round.
Enable Injections, a US-based medical device developer, has raised $215m in a series C round featuring Ohio Innovation Fund, the venture capital vehicle co-founded by Ohio State University, Ohio University and Kent State University.
Magnetar Capital led the round, which also attracted Cincinnati Children’s Hospital Medical Center, CincyTech, Cintrifuse, GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners and unnamed others.
Enable Injections is working on a drug delivery technology that…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
